Literature DB >> 10232680

Endothelial dysfunction in acute renal failure: role of circulating and tissue endothelin-1.

F Ruschitzka1, S Shaw, D Gygi, G Noll, M Barton, T F Lüscher.   

Abstract

The kidney is an important target and source of the potent vasoconstrictor and mitogen endothelin-1 (ET-1). However, its exact role in acute renal failure (ARF) remains to be determined. ARF was induced in male Wistar-Kyoto rats (n = 7) in a 2-kidney, 2-clip model of 30-min clamping. Twenty-four hours after clamp release, contractions to angiotensin I (Angl) and II, ET-1, and big ET-1 were studied in isolated aortic and renal artery rings. Endothelium-dependent and -independent relaxations were assessed by acetylcholine and sodium nitroprusside. ET-1 clearance, tissue uptake, plasma levels, and vascular and kidney content were investigated. In addition, ET(A) and Et(B) receptor mRNA expression was determined. Sham-operated animals served as controls (n = 7). In ARF, ET-1 plasma levels and tissue content of the renal artery, the aorta, and the kidney markedly increased (P<0.01). Plasma half-life of radiolabeled 125I-ET-1 was markedly prolonged, whereas 125I-ET-1 tissue uptake decreased in the kidney in ARF. Contractions to AngI and AngII were blunted (P<0.05) and those to KCl were unchanged, whereas vascular responses to big ET-1 and ET-1 were enhanced in the renal artery and also in the aorta in ARF (P<0.05 to 0.001). Correspondingly, ET(A) and Et(B) receptor mRNA expression significantly increased in both vascular beds. In addition, endothelium-dependent relaxation to acetylcholine was diminished and inversely correlated with vascular ET-1 protein levels in the renal artery (r = -0.827, P<0.001) and the aorta (r = -0.812, P<0.001). In conclusion, the present study demonstrates that increase of circulating and tissue ET-1 protein levels and ET(A) and Et(B) receptor gene expression occurs, which induces endothelial dysfunction and enhanced vasoconstriction in different vascular beds in ARF.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10232680     DOI: 10.1681/ASN.V105953

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  9 in total

1.  Proton Pump Inhibitors Are Not Associated With Acute Kidney Injury in Critical Illness.

Authors:  Joon Lee; Roger G Mark; Leo Anthony Celi; John Danziger
Journal:  J Clin Pharmacol       Date:  2016-09-12       Impact factor: 3.126

Review 2.  Acute renal failure in children: aetiology and management.

Authors:  G Filler
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 3.  Endothelin and the renal microcirculation.

Authors:  Zhengrong Guan; Justin P VanBeusecum; Edward W Inscho
Journal:  Semin Nephrol       Date:  2015-03       Impact factor: 5.299

4.  Purtscher-like retinopathy associated with squamous cell carcinoma of the cervix.

Authors:  Darren Shu Jeng Ting; Jonathan Smith; Stephen James Talks
Journal:  Int Ophthalmol       Date:  2017-02-06       Impact factor: 2.031

Review 5.  Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome.

Authors:  Hadi A R Hadi; Cornelia S Carr; Jassim Al Suwaidi
Journal:  Vasc Health Risk Manag       Date:  2005

Review 6.  Endothelin and the podocyte.

Authors:  Matthias Barton; Pierre-Louis Tharaux
Journal:  Clin Kidney J       Date:  2012-02

7.  Preventive Role of Endothelin Antagonist on Kidney Ischemia: Reperfusion Injury in Male and Female Rats.

Authors:  Nazgol Esmalian Afyouni; Hanieh Halili; Fatemeh Moslemi; Mehdi Nematbakhsh; Ardeshir Talebi; Soheila Shirdavani; Maryam Maleki
Journal:  Int J Prev Med       Date:  2015-12-23

Review 8.  Acute kidney injury in children.

Authors:  Sharon Phillips Andreoli
Journal:  Pediatr Nephrol       Date:  2008-12-13       Impact factor: 3.714

9.  Synergistic effect of renalase and chronic kidney disease on endothelin-1 in patients with coronary artery disease ‒ a cross-sectional study.

Authors:  Yu-Hsuan Li; Wayne Huey-Herng Sheu; Wen-Jane Lee; Jun -Sing Wang; Chia-Po Fu; Kae-Woei Liang; I-Te Lee
Journal:  Sci Rep       Date:  2018-05-09       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.